Method of treating a musculoskeletal disorder or connective tissue disorder in a subject with prostate cancer with the GNRH antagonist Degarelix

• 收藏
• 分享

专利权人:

FERRING INTERNATIONAL CENTER S.A.

发明人:

PERSSON, BO-ERIC,OLESEN, TINE KOLD,CANTOR, PER,VAN DER MEULEN, EGBERT A

申请号：

NZ60395809

公开号：

NZ603958A

申请日:

2009.02.10

申请国别(地区):

NZ

年份:

2013

代理人:

摘要：

603958 Disclosed is the use of degarelix in the manufacture of a medicament for the reduction of musculoskeletal disorder and/or connective tissue disorder in a subject treated for prostate cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/